Position in ZYME
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,726,514
-$201,805 QoQ
Shares Held
219,071
-7.5% QoQ
Ownership
0.309%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 202 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Derivatives in ZYME
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$1,708,000
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. ZYME ranks #136 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ZYME
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,726,514 | 219,071 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,928,319 | 236,754 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $2,357,165 | 89,524 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,286,584 | 75,327 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $1,708,000 | 100,000 | Put | Defined | 2026-02-03 | |
| 2025-06-30 | $1,134,243 | 90,378 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $739,979 | 62,131 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $464,087 | 31,700 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $875,111 | 69,730 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $783,055 | 92,016 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $560,799 | 53,308 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $983,340 | 94,643 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $568,697 | 89,700 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $663,153 | 76,754 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $979,528 | 108,355 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $220,920 | 28,107 | Shares | Defined | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||